Recent Press Releases

EastGate Acquisitions Augments Its Sub-Micron Self-Nanoemulsifying Platform Technology

SALT LAKE CITY and TORONTO, Aug. 18 , 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development...

Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024

NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed...

Stimuli-Responsive Drug Delivery System Prevents Transplant Rejection, Reduces Toxicity, and Lasts for Months

Press Release - Aug 13, 2014 Boston, MA - Following a tissue graft transplant-such as that of the face, hand, arm or leg-it is standard for doctors to immediately give transplant recipients...

FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD

Published: Aug 14, 2014 4:35 p.m. ET Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc....

Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520

August 12, 2014 04:01 PM Eastern Daylight Time PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics,...

BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA

BEMA Buprenorphine on track for late 2014 or early 2015 NDA filing by partner Endo Pharmaceuticals RALEIGH, N.C., Aug. 12, 2014-- BioDelivery Sciences International, Inc. BDSI -1.51% announced that...

BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy

Aug 06, 2014 07:00 ET RALEIGH, N.C., Aug. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has completed a pre-specified interim analysis of the...

BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes

BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes FRANKLIN LAKES, N.J., Aug. 6, 2014 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson...

biOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the Brain

biOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the Brain The Ability to Deliver siRNAs to the Brain Represents a Major Advancement in the Potential...

Surprise discovery could see graphene used to improve health

A chance discovery about the 'wonder material' graphene – already exciting scientists because of its potential uses in electronics, energy storage and energy generation – takes it...

FAMU Researchers Awarded 100K National Science Foundation Grant

Tallahassee, Florida (PRWEB) July 29, 2014 Florida Agricultural and Mechanical University (FAMU) has been awarded a $100,000 grant by the National Science Foundation (NSF) Division of Materials...

MTTI and National Health Research Institutes Have Joined Forces in Developing Novel Cancer Therapeutics

WEST CHESTER, Pa.--()--Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI), Taiwan announced today that the two parties have formed a joint...

Mystic Pharmaceuticals Receives Notice of Allowance for Novel Powder Drug Delivery Technology

AUSTIN, Texas--()--Mystic Pharmaceuticals, Inc., a privately held, integrated specialty pharmaceutical company, announced today it has received a Notice of Allowance from the United...

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method

PITTSBURGH—Researchers from Carnegie Mellon University have developed a novel method for creating self-assembled protein/polymer nanostructures that are reminiscent of fibers found in living...

STENTYS Reallocates Resources to Focus on its Advanced Drug-Eluting Stent Program

PRINCETON, N.J. and PARIS – July 31, 2014 – STENTYS (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing®...

Global Transdermal Drug Delivery Market 2014-2018

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Transdermal Drug Delivery Market 2014-2018...

EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology

SALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of...

Phosphagenics Provides Update on Opioid Patch Program

MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- Next phase of the TPM®/Oxymorphone clinical development program has commenced TPM®/Oxycodone Phase 2a trial to be conducted in Australia...

Oraya Therapeutics Announces Rapid Expansion in Europe as More Hospitals Offer Oraya Therapy for Treating Wet AMD

First National Health Service hospital in UK and four prestigious hospitals in Germany adopt Oraya Therapy to maintain vision with reduced anti-VEGF injections NEWARK, Calif., July 22,...

Scientists test a Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer

Released: 25-Jul-2014 9:30 AM EDT Source Newsroom: Norris Cotton Cancer CenterDartmouth-Hitchcock Medical Center more news from this source Contact Information Available for logged-in reporters only...